Trial Profile
A retrospective multicentre study of tocilizumab in patients with giant cell arteritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Adverse reactions; Therapeutic Use
- 15 May 2016 Results published in The Journal of Rheumatology
- 02 Feb 2016 New trial record